J. P. Nadda releases Indian Pharmacopoeia 2026, the 10th edition
On 2 January 2026 at Dr. Ambedkar International Centre, New Delhi, Union Health Minister J. P. Nadda released Indian Pharmacopoeia 2026, the 10th edition of India's official book of drug standards, with 121 new monographs.
Summary
On 2 January 2026 at Dr. Ambedkar International Centre, New Delhi, Union Health Minister J. P. Nadda released Indian Pharmacopoeia 2026 (IP 2026), the 10th edition of India's official book of drug standards. IP 2026 adds 121 new monographs, taking the total to 3,340, strengthens coverage of anti-tubercular, anti-diabetic and anti-cancer medicines, and for the first time includes 20 blood component monographs for transfusion medicine. Nadda said the Indian Pharmacopoeia is now recognised in 19 countries of the Global South and that India has risen from 123rd (2009â2014) to 8th in 2025 in contributions to the WHO pharmacovigilance database; the Indian Pharmacopoeia is published by the Indian Pharmacopoeia Commission to fulfil the requirements of the Drugs and Cosmetics Act, 1940.
Key facts
- Edition
- Indian Pharmacopoeia 2026 â 10th edition
- Released
- 2 January 2026, Dr. Ambedkar International Centre, New Delhi
- Monographs
- 121 new; total 3,340
- First
- 20 blood component monographs (transfusion medicine)
- Recognition
- 19 Global South countries
- Pharmacovigilance
- India 123rd (2009â14) → 8th (2025) in WHO database contributions
- Publisher / law
- Indian Pharmacopoeia Commission; Drugs and Cosmetics Act, 1940
Practice MCQs 3 questions
Indian Pharmacopoeia 2026, released on 2 January 2026, is which edition of India's official book of drug standards?
Show answer
Correct answer: D â 10th
PIB (Health): IP 2026 is the 10th edition of India's official book of drug standards.
Which new category of monographs has been included for the first time in Indian Pharmacopoeia 2026?
Show answer
Correct answer: A â Blood component monographs for transfusion medicine
PIB (Health): IP 2026 includes, for the first time, 20 blood component monographs pertaining to transfusion medicine.
Consider the following statements about the Indian Pharmacopoeia (IP): 1. IP is published by the Indian Pharmacopoeia Commission to fulfil the requirements of the Drugs and Cosmetics Act, 1940. 2. IP is recognised in 19 countries of the Global South. 3. India ranked 8th in 2025 in contributions to the WHO pharmacovigilance database, up from 123rd in 2009â2014. Which of the statements given above is/are correct?
Show answer
Correct answer: C â 1, 2 and 3
PIB (Health): IP is published by the IPC under the Drugs and Cosmetics Act, 1940; it is recognised in 19 Global South countries; and India rose from 123rd (2009â2014) to 8th (2025). All three are correct.